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Letters to the Editors
Effectiveness of X-ray and computed tomography screen-
ing for assessing pulmonary involvement in patients with
head and neck squamous cell carcinoma
J Laryngol Otol 2008;122:961–6
Dear Sirs
We read with great interest the article by Leong et al. pub-
lished recently in The Journal of Laryngology & Otology.1
These authors analysed the effectiveness of X-ray and com-
puted tomography (CT) in the detection of lung metastases
or synchronous lung primary tumours in patients with
newly diagnosed head and neck squamous cell carcinoma
(SCC), and they assessed the factors associated with posi-
tive findings.
Detection of distant metastases or synchronous second
primary tumours at the time of initial evaluation clearly
influences the selection of treatment in head and neck
SCC patients. Patients with distant metastases are gener-
ally not considered curable and almost always receive
only palliative treatment. If a synchronous second
primary tumour is present, the choice of treatment is dic-
tated by the primary tumour with the worst prognosis.
The authors recommend chest CT screening in newly
diagnosed cases of head and neck SCC. However, the inci-
dence of distant metastasis is generally too low to warrant
an extensive radiographic staging evaluation, nor does the
incidence of synchronous second primary tumours justify
screening for these lesions. Only patients with advanced
stage disease should undergo routine scanning for distant
metastases.2,3 Commendably, the authors compare both
imaging techniques ‘head to head’. Plain X-ray of the
thorax detects a minority of all malignant pulmonary
lesions detected by CT.2,3 The authors found a sensitivity
of 100 per cent for CT and 35.7 per cent for X-ray.
However, they use CT (repeated in the case of suspicious
findings) as the ‘gold’ (reference) standard with which to
obtain accuracy data. Previous studies have shown that
CT scanning frequently misses lung metastases.4 There-
fore, the only fully reliable gold standard is long term
follow up or autopsy. Although the longer the follow up
the more reliable the reference standard, a follow up of
12 months seems to be sufficient, since the vast majority
of distant metastases will become manifest within this
period.
Unfortunately, follow up of patients with negative CT
screening is rarely reported, and Leong and colleagues’
study is no exception. Distant metastases that appear
during follow up in patients who achieved loco-regional
control must have arisen from subclinical distant spread
already present at the time of treatment. Thus, if patients
with loco-regional control develop distant metastases
despite negative screening, these distant metastases must
have been missed by (i.e. were below the detection limit
of) the technique used for screening (e.g. CT of the
thorax). In a recent study, we found that CT failed to
detect malignant abnormalities in the thorax in at least
22 per cent of head and neck SCC patients.4 Because
follow up in Leong and colleagues’ study is lacking, sensi-
tivity is overestimated and thus less meaningful.
Furthermore, it is not clear how the authors attempted to
determine the nature of abnormal CT findings, which is
vital. In several studies in which screening for distant
metastases was investigated, attempts were made to deter-
mine the nature of abnormal or suspicious CT findings.
Screening was considered to be true positive when there
was: an evident metastasis or second primary tumour on
CT; thorax CT scan lesions which were progressive on
two successive CT scans with an interval of three months;
or malignancy revealed by histopathological examination
of tissue obtained by bronchoscopy, thoracoscopy or
thoracotomy.2 – 4 These additional examinations appeared
to be helpful.2 Leong et al. seem to use only a screening
CT and, for suspicious lesions, a repeated CT scan.
Leong and colleagues mention some disadvantages of
fluoro-deoxy-glucose positron emission tomography (FDG-
PET), and state that FDG-PET may not abrogate CT in
the detection of distant metastases and synchronous second
primary tumours. Indeed, two recent studies showed that
the combination of FDG-PET and CT detected distant
metastases in more head and neck SCC patients, compared
with either imaging modality alone.5,6
We support the authors’ attempt to identify risk factors.
There is indeed a need for clear guidelines for staging the
disease with respect to distant metastases in head and
neck SCC patients.7 We would recommend the use of CT
and FDG-PET only in patients with high risk factors for
distant metastases. Adequate staging (and screening for
second primary tumours) decreases over-treatment by
reducing the number of futile extensive treatments.
R de Bree
O S Hoekstra
J A Castelijns
C R Leemans
Department of Otolaryngology, Head and Neck Surgery,
VU University Medical Centre,
Amsterdam,
The Netherlands.
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Authors’ reply
Dear Sirs
We thank de Bree et al. for their comments regarding our
article.
We agree that if a synchronous secondary primary
tumour is present, the choice of treatment is dictated by
the primary tumour with the worst prognosis, although
other considerations such as quality of life and
co-morbidities would also be considered. Whilst we
agree that the incidence of distant metastasis is low, the
objective of our study was to evaluate the benefits of
radiological screening and the incidence of pulmonary
involvement in newly diagnosed head and neck cancers.
Dr de Bree and colleagues also state that distant metas-
tases appearing during follow up in patients who have
achieved loco-regional control must have arisen from sub-
clinical distant spread already present at the time of treat-
ment. We did not find any references to support this
assumption. We found the discussion on FDG-PET in
high-risk patients very informative, and would take this
into consideration in any future reports from the depart-
ment. We appreciate that there are variations of practice
between countries; FDG-PET is not currently standard
practice in our department.
We would again like to thank de Bree et al. for their inter-
est in our paper, and we have taken note of their points.
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